| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.08 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |